GE's 1Q performance tops Wall Street's view

Associated Press |

BOSTON (AP) _ General Electric Co. (GE) on Friday reported first-quarter net income of $653 million, after reporting a loss in the same period a year earlier.

On a per-share basis, the Boston-based company said it had profit of 7 cents. Earnings, adjusted for non-recurring costs and to account for discontinued operations, were 21 cents per share.

The results topped Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of 17 cents per share.



The industrial conglomerate posted revenue of $27.66 billion in the period, which also beat Street forecasts. Five analysts surveyed by Zacks expected $26.36 billion.

GE expects full-year earnings in the range of $1.60 to $1.70 per share.

GE shares have dropped 4 percent since the beginning of the year, while the Standard & Poor's 500 index has increased 5 percent. The stock has decreased roughly 3 percent in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GE at https://www.zacks.com/ap/GE

Keywords: General Electric, Earnings Report, Priority Earnings

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Pressure Biosciences Inc

Pressure BioSciences Inc is a biological life sciences research company. It is engaged in the development and commercialization of a platform technology called pressure cycling technology.

Private Markets

Voleo

Voleo is a free download that allows you to form investment clubs with your friends, family, colleagues, classmates, teammates…basically anyone you know and trust. Invest and manage a stock portfolio…

The Green Organic Dutchman

The Green Organic Dutchman Ltd. ("TGOD") produces farm grown, organic cannabis for medical use. The company grows its high quality organic cannabis in small batches using craft growing, all natural…